Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Transradial Approach for Transcatheter Arterial Chemoembolization in Patients With Hepatocellular Carcinoma: Comparison with Conventional Transfemoral Approach

Shiozawa, Shunichi MD; Tsuchiya, Akira MD; Endo, Shungo MD; Kato, Hiroyuki MD; Katsube, Takao MD; Kumazawa, Kenichi MD; Naritaka, Yoshihiko MD; Ogawa, Kenji MD

Journal of Clinical Gastroenterology: November-December 2003 - Volume 37 - Issue 5 - p 412-417
Liver, Pancreas, and Biliary Tract: Clinical Research

We evaluated the clinical usefulness and safety of transradial approach for transcatheter arterial chemoembolization (TACE) in patients with hepatocellular carcinoma (HCC) compared with that of conventional transfemoral approach. The two groups (radial group, n = 177; femoral group, n = 150) of cases were retrospectively compared with regard to the successful rate of angiography or TACE, time required for catheterizaiton and complications. Hepatic angiography and TACE were completed in 174 (98.3%) of 177 cases in the radial group. There was no intergroup difference of time required for catheterization. Minor complications (dull pain, numbness) occurred in 8 (4.6%) patients in the radial group, and there were lower complications in the radial group compared to the femoral group. TACE by our new transradial approach was found to have therapeutic efficacy with lower complications comparable to that of the conventional transfemoral approach.

From the Department of Surgery, Tokyo Women's Medical University Daini Hospital, Japan (Drs Shiozawa, Tsuchiya, Kato, Katsube, Kumazawa, Naritaka, and Ogawa); and Showa University Northern Yokohama Hospital Digestive Center (Dr Endo).

Received for publication December 17, 2002; accepted May 02, 2003.

Address correspondence and reprint requests to Dr. Shunichi Shiozawa, Department of Surgery, Tokyo Women's Medical University Daini Hospital, 2-1-10 Nishioku, Arakawa-ku, Tokyo, 116-8567, Japan (e-mail:

© 2003 Lippincott Williams & Wilkins, Inc.